No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
No Data
Helix Launches Clinico-Genomic Datasets for Cardiovascular, Metabolic, Immunology and Inflammation Disorders
Rich longitudinal clinical and genomic data through a network of diverse U.S. health systems.SAN MATEO, Calif.--(BUSINESS WIRE)--Helix, the leading population genomics company, is launching new clinic
Helix BioPharma Corp. Advances Despite Filing Delay
Helix BioPharma Corp. Progresses Amid Delays
Canadian Investment Regulatory Organization Trade Resumption - HBP
Helix BioPharma Corp. Secures New Funding
Canadian Investment Regulatory Organization Trading Halt - HBP